Related Experiment Video
Updated: Sep 10, 2025
Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Association between cardiometabolic phenotypes with atherogenic index of plasma: a cross-sectional study from the
Shirin Soheilifard1, Elnaz Faramarzi2, Reza Mahdavi3
1Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Background:
Cardiometabolic phenotypes combine metabolic health and obesity measures for a more accurate cardiovascular risk assessment than body mass index (BMI) alone. The Atherogenic Index of Plasma (AIP), based on triglycerides and high-density lipoprotein cholesterol (HDL-C), is a promising cardiovascular disease (CVD) risk marker. This study explores the relationship between cardiometabolic phenotypes and AIP to improve understanding of their combined predictive value for CVD risk.
Methods:
This cross-sectional study analyzed data from 9,515 participants aged 35-55 in the Azar Cohort Study. Metabolic syndrome (MetS) was defined using ATP III criteria. Participants were classified into four phenotypes: metabolically healthy normal weight (MHNW, BMI < 25 kg/m2), metabolically unhealthy normal weight (MUHNW, BMI < 25 kg/m2), metabolically healthy obese (MHO, BMI ≥ 25 kg/m2), and metabolically unhealthy obese (MUHO, BMI ≥ 25 kg/m2). AIP was calculated as the logarithm of triglycerides to HDL. Multinomial regression was used to analyze the relationship between AIP tertiles and phenotypes using both unadjusted and adjusted models. Confounders were controlled for across the three groups.
Results:
Among participants, 50.4% were classified as MHO and 28.2% as MUHO. High-risk AIP levels (> 0.21) were found in 79.6% of MUHNW and 64.6% of MUHO, compared to 18.6% of MHO and 13.5% of MHNW. After adjusting for age, physical activity (METs), the wealth score index (WSI), and smoking status, the odds ratios (ORs) for cardiometabolic phenotypes in the high-risk AIP group remained significant. At the high-risk level, MUHNW (OR = 63.49, p < 0.001), MHO (OR = 1.96, p < 0.001), and MUHO (OR = 32.15, p < 0.001) showed significant associations.
Conclusion:
In this study, significant associations were found between cardiometabolic phenotypes and AIP. Findings emphasize integrating metabolic health assessments with AIP to improve CVD risk identification. Prospective longitudinal studies are also needed to confirm these associations.
More Related Videos
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:26Atherosclerosis III: Management
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Atherosclerosis I: Introduction